254 results on '"Albertsen, Birgitte Klug"'
Search Results
2. A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings
3. A prospective evaluation of the diagnostic potential of EBV-DNA in plasma and whole blood
4. Temporal changes in incidence of relapse and outcome after relapse of childhood acute lymphoblastic leukemia over three decades; a Nordic population-based cohort study
5. Endothelial dysfunction and thromboembolism in children, adolescents, and young adults with acute lymphoblastic leukemia
6. Pancreas-related persisting sequelae in ALL survivors with a history of asparaginase-associated pancreatitis:A part of the ALL-STAR study
7. Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia: a NOPHO ALL2008 study
8. Quality of life in children and adolescents after treatment for acute lymphoblastic leukemia according to the NOPHO ALL2008 protocol.
9. Sequelae and post‐thrombotic syndrome after venous thromboembolism in acute lymphoblastic leukemia survivors treated on the NOPHO ALL2008 protocol
10. Pancreas‐related persisting sequelae in ALL survivors with a history of asparaginase‐associated pancreatitis: A part of the ALL‐STAR study
11. Phagocyte-related S100 proteins and cytokines in acute lymphoblastic leukemia and their prognostic value
12. Parental experiences of the informed consent process in randomized clinical trials—A Nordic study
13. Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years
14. Long-term effects of asparaginase-associated pancreatitis
15. Correlation between asparaginase enzyme activity levels and coagulation parameters during childhood acute lymphoblastic leukemia treatment
16. Parental experiences of the informed consent process in randomized clinical trials-A Nordic study
17. Correlation between asparaginase enzyme activity levels and coagulation parameters during childhood acute lymphoblastic leukemia treatment
18. Pharmacokinetics and Immunogenicity of the First Doses of Peg-Asparaginase -an Alltogether Pilot Study
19. Correction: Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology study
20. PHAGOCYTE-RELATED S100 PROTEINS AND CYTOKINES IN ACUTE LYMPHOBLASTIC LEUKEMIA AT DIAGNOSIS AND FOLLOW-UP MAY IMPROVE PREDICTION OF MINIMAL RESIDUAL DISEASE
21. A survey on thromboprophylaxis and coagulation assessment in children and young adults with acute lymphoblastic leukaemia ( ALL ) in the Nordic and Baltic countries: Different practices of assessment and management
22. Asparaginase encapsulated in erythrocytes as second‐line treatment in hypersensitive patients with acute lymphoblastic leukaemia
23. Individualized 6‐mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: A NOPHO randomized controlled trial
24. A survey on thromboprophylaxis and coagulation assessment in children and young adults with acute lymphoblastic leukaemia (ALL) in the Nordic and Baltic countries : Different practices of assessment and management
25. Obesity as a predictor of treatment-related toxicity in children with acute lymphoblastic leukaemia
26. M-ficolin : a valuable biomarker to identify leukaemia from juvenile idiopathic arthritis
27. Cerebral sinovenous thrombosis and asparaginase re-exposure in patients aged 1-45 years with acute lymphoblastic leukaemia:A NOPHO ALL2008 study
28. Asparaginase encapsulated in erythrocytes as second-line treatment in hypersensitive patients with acute lymphoblastic leukaemia
29. High CD34 surface expression in BCP-ALL predicts poor induction therapy response and is associated with altered expression of genes related to cell migration and adhesion
30. Changes in body mass index during treatment of childhood acute lymphoblastic leukemia with the Nordic ALL2008 protocol
31. Asparaginase encapsulated in erythrocytes as second-line treatment in hypersensitive patients with acute lymphoblastic leukaemia
32. Socioeconomic position and maintenance therapy in children with acute lymphoblastic leukemia:A national cohort study
33. Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia:a NOPHO ALL2008 study
34. Cerebral sinovenous thrombosis and asparaginase re‐exposure in patients aged 1–45 years with acute lymphoblastic leukaemia: A NOPHO ALL2008 study
35. High CD34 surface expression in BCP‐ALL predicts poor induction therapy response and is associated with altered expression of genes related to cell migration and adhesion
36. Asparaginase encapsulated in erythrocytes as second‐line treatment in hypersensitive patients with acute lymphoblastic leukaemia
37. Socioeconomic position and maintenance therapy in children with acute lymphoblastic leukemia: A national cohort study
38. A Meta-Analysis of Hypersensitivity to Pegylated Escherichia coli Asparaginase Used As First-Line Treatment in Contemporary Pediatric Acute Lymphoblastic Leukemia Protocols
39. Obesity as a predictor of treatment‐related toxicity in children with acute lymphoblastic leukaemia
40. M-ficolin: a valuable biomarker to identify leukaemia from juvenile idiopathic arthritis
41. Parents’ and Adolescents’ Preferences for Intensified or Reduced Treatment in Randomized Lymphoblastic Leukemia Trials
42. Endothelial dysfunction and thromboembolism in children, adolescents, and young adults with acute lymphoblastic leukemia
43. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol
44. Flow cytometric analysis of cerebrospinal fluid improves detection of leukaemic blasts in infants with acute lymphoblastic leukaemia
45. Relapse risk following truncation of PEG-asparaginase in childhood acute lymphoblastic leukemia
46. National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia:the ALL-STAR study protocol
47. Socioeconomic position and maintenance therapy in children with acute lymphoblastic leukemia: A national cohort study.
48. Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia
49. Risk of ocular hypertension in children treated with systemic glucocorticoid
50. Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia : a Nordic Society of Pediatric Hematology and Oncology study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.